tiprankstipranks
Trending News
More News >
Meiragtx Holdings Plc (MGTX)
NASDAQ:MGTX
US Market
Advertisement

Meiragtx Holdings (MGTX) Drug Pipeline

Compare
468 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Aav2-Haqp1
Grade 2 And 3 Late Xerostomia Caused By Radiotherapy For Cancers Of The Upper Aerodigestive Tract, Excluding The Parotid Glands
Phase II
Enrolling By Invitation
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
Aug 05, 2024
Aav2-Haqp1 Concentration 1, Aav2-Haqp1 Concentration 2, Aav2-Haqp1 Concentration 3, Aav2-Haqp1 Concentration 4
Grade 2 And 3 Late Xerostomia Caused By Radiotherapy For Cancers Of The Upper Aerodigestive Tract, Excluding The Parotid Glands
Phase II
Recruiting
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
Jun 22, 2023
Aav-Gad
Parkinson's Disease
Phase I/II
Active Not Recruiting
Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease
May 30, 2023
Aav-Gad Low Dose, Aav-Gad High Dose, Sham Surgery
Parkinson's Disease
Phase I/II
Completed
A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants
Oct 12, 2022
Aav2haqp1
Squamous Cell Head And Neck Cancer, Radiation Induced Xerostomia, Salivary Hypofunction
Phase I
Active Not Recruiting
Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction
May 14, 2015

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Meiragtx Holdings Plc (MGTX) have in its pipeline
      MGTX is currently developing the following drugs: Aav2-Haqp1, Aav2-Haqp1 Concentration 1, Aav2-Haqp1 Concentration 2, Aav2-Haqp1 Concentration 3, Aav2-Haqp1 Concentration 4, Aav-Gad. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis